MORTALIN-Ca(2+) axis drives innate rituximab resistance in diffuse large B-cell lymphoma. Sun Q, Ye Y, Gui A, Sun X, et al. Cancer Lett 2022 Apr 18:215678. doi: 10.1016/j.canlet.2022.215678.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sun Q, Ye Y, Gui A, Sun X, et al. MORTALIN-Ca(2+) axis drives innate rituximab resistance in diffuse large B-cell lymphoma. Cancer Lett 2022 Apr 18:215678. doi: 10.1016/j.canlet.2022.215678.
PMID: 35447282